U.S. Physical Therapy locks $171M of debt costs, but adds no growth capital

USPH is a national outpatient physical-therapy and industrial-injury-prevention operator using acquisitions, clinic partnerships, and a recently refinanced credit facility to fund growth. Its April 2026 financing included a $175 million term loan and $275 million revolver, with the revolver available for acquisitions and other corporate uses.

The filing is mainly a rollover of existing rate protection. USPH entered a forward-starting swap because its current hedge expires June 30, 2027; the new hedge starts then and runs to April 14, 2031. 〔0〕 The timing was therefore largely foreseeable from the refinancing and existing swap maturity, making this a detail update rather than a new strategic development.

It improves cost visibility, not operating momentum. The company will exchange one-month SOFR exposure for a fixed 4.578% rate on roughly $171 million of declining term debt. 〔1〕 That should make interest expense easier to plan from June 2027 onward, but it also means USPH will not benefit from lower short-term rates on the hedged balance.

The hedge does not add funding or alter the growth story. No new borrowing proceeds, acquisition, covenant change, or operating outlook is disclosed; this is a financing-risk management action attached to debt USPH already took on. The market likely expected some replacement hedge once the old swap matured, so the fixed rate and amortization schedule are the news—not a change in the business trajectory.

Bottom line: USPH has secured longer-term visibility on borrowing costs, but this is a routine financing step that barely changes the underlying company story.